venetoclax
Showing 1 - 25 of 243
Chronic Myeloid Leukemia Trial in Jena (Venetoclax)
Not yet recruiting
- Chronic Myeloid Leukemia
- Venetoclax
-
Jena, GermanyUniversitätsklinikum Jena
Jan 17, 2023
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Boston (Venetoclax, Obinutuzumab, Rituximab)
Recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Venetoclax
- +2 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Jun 1, 2022
Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Decitabine, Navitoclax, Venetoclax)
Recruiting
- Recurrent Acute Myeloid Leukemia
- Refractory Acute Myeloid Leukemia
- Decitabine
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 15, 2022
Hemophagocytic Lymphohistiocytosis Trial in Beijing (Venetoclax, Dexamethasone, Etoposide)
Recruiting
- Hemophagocytic Lymphohistiocytosis
- Venetoclax
- +2 more
-
Beijing, Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Sep 15, 2022
Acute Myeloid Leukemia, Mixed Lineage Acute Leukemia, Mixed Lineage Leukemia Gene Mutation Trial (Ziftomenib, Venetoclax,
Not yet recruiting
- Acute Myeloid Leukemia
- +10 more
- Ziftomenib
- +4 more
- (no location specified)
Feb 17, 2023
Chronic Lymphocytic Leukemia Trial (Venetoclax)
Not yet recruiting
- Chronic Lymphocytic Leukemia
- Venetoclax
- (no location specified)
Apr 2, 2022
Lymphoma, Non-Hodgkin, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in New York (Venetoclax, Tazemetostat)
Not yet recruiting
- Lymphoma, Non-Hodgkin
- +2 more
- Venetoclax
- Tazemetostat
-
New York, New YorkWeill Cornell Medicine/NewYork-Presberteryian Hospital
Jan 18, 2023
Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Trial in Tianjin (Olverembatinib, Venetoclax, prednisone)
Recruiting
- Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
- Olverembatinib
- +3 more
-
Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Oct 21, 2022
Waldenstrom Macroglobulinemia, MYD88 Gene Mutation Trial in Boston (IBRUTINIB, Venetoclax)
Active, not recruiting
- Waldenstrom Macroglobulinemia
- MYD88 Gene Mutation
- IBRUTINIB
- Venetoclax
-
Boston, Massachusetts
- +1 more
Apr 1, 2022
Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial in Edegem, Roeselare (Venetoclax, 6-mercaptopurine)
Recruiting
- Acute Myeloid Leukemia, in Relapse
- Acute Myeloid Leukemia Refractory
- Venetoclax
- 6-mercaptopurine
-
Edegem, Antwerp, Belgium
- +1 more
Aug 16, 2022
Acute Myeloid Leukemia, Relapsed Adult AML Trial (Lintuzumab-Ac225, Venetoclax, Azacitidine)
Not yet recruiting
- Acute Myeloid Leukemia
- Relapsed Adult AML
- Lintuzumab-Ac225
- +2 more
- (no location specified)
Feb 22, 2022
Leukemia, Myeloid, Acute Trial in Guanzhou (Azacitidine, Venetoclax)
Not yet recruiting
- Leukemia, Myeloid, Acute
- Azacitidine
- Venetoclax
-
Guanzhou, Guandong, ChinaNanfang Hospital of Southern Medical University
Jul 22, 2022
Diffuse Large B Cell Lymphoma, Relapsed DLBCL, Refractory DLBCL Trial in Boston (Copanlisib, Venetoclax)
Recruiting
- Diffuse Large B Cell Lymphoma
- +2 more
- Copanlisib
- Venetoclax
-
Boston, MassachusettsDana-Farber Cancer Institute
May 4, 2022
Waldenstrom Macroglobulinemia, B-Cell Lymphoproliferative Disorder Trial in Boston (Pirtobrutinib, Venetoclax, Allopurinol)
Not yet recruiting
- Waldenstrom Macroglobulinemia
- B-Cell Lymphoproliferative Disorder
- Pirtobrutinib
- +2 more
-
Boston, Massachusetts
- +2 more
Feb 18, 2023
Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma, Acute Myeloid Leukemia (AML) Trial (Venetoclax)
Available
- Chronic Lymphocytic Leukemia (CLL)
- +6 more
- Venetoclax
- (no location specified)
Mar 28, 2022
HIV-1-infection Trial in Aarhus (Venetoclax)
Not yet recruiting
- HIV-1-infection
- Venetoclax
-
Aarhus, DenmarkAarhus University Hospital
Jan 5, 2023
Acute Lymphoblastic Leukemia Trial in New York (Venetoclax)
Recruiting
- Acute Lymphoblastic Leukemia
- Venetoclax
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jun 17, 2022
Venetoclax in Patients With Acute Myeloid Leukemia
Recruiting
- Acute Myeloid Leukemia
- Venetoclax
-
Taipei, TaiwanNational Taiwan University Hospital
Oct 27, 2021
AML, Adult, Chemo Effect Trial in Suzhou (Venetoclax, Decitabine for Injection, Cytarabine)
Recruiting
- AML, Adult
- Chemotherapy Effect
- Venetoclax
- +3 more
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University, Jiangsu Ins
Feb 28, 2022
Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia Trial in Tianjin (Vincristine, Daunorubicin, Cyclophosphamide)
Recruiting
- Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia
- Vincristine
- +9 more
-
Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Dec 13, 2022
Venetoclax in Patients With Chronic Lymphocytic Leukemia
Recruiting
- Chronic Lymphocytic Leukemia
- Venetoclax
-
Taipei, TaiwanNational Taiwan University Hospital
Oct 27, 2021
Acute Myeloid Leukemia Trial in Aurora (Azacitidine, Venetoclax)
Recruiting
- Acute Myeloid Leukemia
- Azacitidine
- Venetoclax
-
Aurora, ColoradoUniverstiy of Colorado Hospital
Feb 15, 2022